LT3471732T - Liposomos, skirtos virusinių infekcijų gydymui - Google Patents

Liposomos, skirtos virusinių infekcijų gydymui

Info

Publication number
LT3471732T
LT3471732T LTEP17731852.4T LT17731852T LT3471732T LT 3471732 T LT3471732 T LT 3471732T LT 17731852 T LT17731852 T LT 17731852T LT 3471732 T LT3471732 T LT 3471732T
Authority
LT
Lithuania
Prior art keywords
liposomes
treatment
viral infections
infections
viral
Prior art date
Application number
LTEP17731852.4T
Other languages
English (en)
Inventor
Samareh Azeredo Da Silveira Lajaunias
Frédéric LAJAUNIAS
Original Assignee
Combioxin Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combioxin Sa filed Critical Combioxin Sa
Publication of LT3471732T publication Critical patent/LT3471732T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP17731852.4T 2016-06-16 2017-06-15 Liposomos, skirtos virusinių infekcijų gydymui LT3471732T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16174700 2016-06-16
PCT/EP2017/064653 WO2017216282A1 (en) 2016-06-16 2017-06-15 Liposomes for the treatment of viral infections

Publications (1)

Publication Number Publication Date
LT3471732T true LT3471732T (lt) 2020-09-10

Family

ID=56134203

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17731852.4T LT3471732T (lt) 2016-06-16 2017-06-15 Liposomos, skirtos virusinių infekcijų gydymui

Country Status (12)

Country Link
US (2) US20190328663A1 (lt)
EP (1) EP3471732B1 (lt)
DK (1) DK3471732T3 (lt)
ES (1) ES2811025T3 (lt)
HR (1) HRP20201257T1 (lt)
HU (1) HUE049939T2 (lt)
LT (1) LT3471732T (lt)
PL (1) PL3471732T3 (lt)
PT (1) PT3471732T (lt)
RS (1) RS60602B1 (lt)
SI (1) SI3471732T1 (lt)
WO (1) WO2017216282A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015084677A1 (en) 2013-12-02 2015-06-11 Arytha Biosciences, Llc Toxoid preparation and uses thereof
CA3097045A1 (en) * 2018-04-20 2019-10-24 Samareh Azeredo Da Silveira Lajaunias Treatment of sepsis and septic shock

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007252967B2 (en) * 2006-05-19 2011-11-10 Viroblock S.A. A composition for inactivating an enveloped virus
RS60951B1 (sr) 2012-06-14 2020-11-30 Univ Bern Lipozomi prilagođeni za lečenje bakterijskih infekcija

Also Published As

Publication number Publication date
SI3471732T1 (sl) 2020-09-30
ES2811025T3 (es) 2021-03-10
EP3471732A1 (en) 2019-04-24
RS60602B1 (sr) 2020-08-31
WO2017216282A1 (en) 2017-12-21
US20190328663A1 (en) 2019-10-31
EP3471732B1 (en) 2020-05-13
US20230028179A1 (en) 2023-01-26
DK3471732T3 (da) 2020-08-17
PL3471732T3 (pl) 2020-10-19
HRP20201257T1 (hr) 2020-11-13
HUE049939T2 (hu) 2020-11-30
PT3471732T (pt) 2020-08-24

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
HK1225968A1 (zh) 用於治療hbv感染的組合療法
ZA201708039B (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
HK1216421A1 (zh) 用於治療病毒感染的治療化合物
ZA201900156B (en) Phosphoramidates for the treatment of hepatitis b virus
EP3233878A4 (en) PHOSPHORAMIDATE FOR THE TREATMENT OF HEPATITIS C VIRUS
SG11201609652RA (en) Treatment of polybacterials infections
HK1258276A1 (zh) 用於治療hiv的化合物和組合
PT3519569T (pt) Vetores de vírus adenoassociados para o tratamento de mucopolissacaridoses
IL256327B (en) Pharmaceutical preparations for the treatment of viral problems of the eye
HK1252343A1 (zh) 用於治療病毒感染的組合物和方法
HK1257272A1 (zh) 治療hiv的工具
ZA201902385B (en) Compounds and methods for diagnosis and treatment of viral infections
HK1247558A1 (zh) 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化
PL3471732T3 (pl) Liposomy do leczenia infekcji wirusowych
RS60451B1 (sr) Novi postupci za dobijanje vemurafeniba
EP3448377A4 (en) METHODS FOR THE TREATMENT OF AN INFECTION
PL3095866T3 (pl) Środek do profilaktyki i terapii infekcji wirusowych
SG10202010317VA (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases
PT3166604T (pt) Agentes para o tratamento de doenças infeciosas retrovirais
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
GB201619704D0 (en) Treatment of pathogenic infections